Stocks and Investing
Stocks and Investing
Mon, February 26, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Julian Harrison Initiated (ANAB) at Strong Buy and Held Target at $55 on, Feb 26th, 2024
Julian Harrison of BTIG, Initiated "AnaptysBio, Inc." (ANAB) at Strong Buy and Held Target at $55 on, Feb 26th, 2024.
Julian has made no other calls on ANAB in the last 4 months.
There are 4 other peers that have a rating on ANAB. Out of the 4 peers that are also analyzing ANAB, 2 agree with Julian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Nierengarten of "Wedbush" Reiterated at Hold and Held Target at $20 on, Wednesday, November 29th, 2023
- Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $21 on, Thursday, November 2nd, 2023
These are the ratings of the 2 analyists that currently disagree with Julian
- Alex Schwartz of "Stifel" Initiated at Strong Buy and Held Target at $50 on, Wednesday, February 21st, 2024
- Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $80 on, Friday, February 16th, 2024
Contributing Sources